Down To Levels Not Seen Since 2016: Initiating Sarepta With A Buy

Sarepta Therapeutics, Inc. (NASDAQ: SRPT ) stock was down 40% in pre-market trading on Monday, June 16th, as seen below. As soon as the market opened, Monday morning losses not only stuck but continued to deepen with the stock down over 47% soI’m a retired Wall Street PM specializing in TMT; since kickstarting my career, I’ve spent over two decades in the market navigating the technology landscape, focusing on risk mitigation through the dot com bubble, credit default of ‘08, and, more recently, with the AI ...